The introduction of novel biologic agents has revolutionized the treatment of the disease in recent years.
Eveline Y. Wu, MD, MSCR
Advertisement
Eveline Y. Wu, MD, MSCR, is division chief, Department of Pediatric Rheumatology, The University of North Carolina at Chapel Hill.
Articles by Eveline Y. Wu, MD, MSCR
Advertisement
Latest Updated Articles
Biologics to the rescue: changing the treatment paradigm in juvenile idiopathic arthritisPublished: April 14th 2023 | Updated:
Advertisement
Advertisement
Trending on Contemporary Pediatrics
1
CDC updates website, opens door for autism and vaccines link
2
Redefining type 1 diabetes: Early identification, staging, and clinical implications for pediatric care
3
FDA approves EYLEA HD injection 8 mg to treat macular edema following RVO and monthly dosing
4
Alice Hoyt, MD, discusses the importance of quick epinephrine use for anaphylaxis
5
